Yoon, W.J.; Oh, Y.; Yoo, C.; Jang, S.; Cho, S.-S.; Suh, J.-H.; Choi, S.-S.; Park, D.H.
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. J. Clin. Med. 2020, 9, 1666.
https://doi.org/10.3390/jcm9061666
AMA Style
Yoon WJ, Oh Y, Yoo C, Jang S, Cho S-S, Suh J-H, Choi S-S, Park DH.
EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. Journal of Clinical Medicine. 2020; 9(6):1666.
https://doi.org/10.3390/jcm9061666
Chicago/Turabian Style
Yoon, Won Jae, Yul Oh, Changhoon Yoo, Sunguk Jang, Seong-Sik Cho, Jeong-Hun Suh, Seong-Soo Choi, and Do Hyun Park.
2020. "EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial" Journal of Clinical Medicine 9, no. 6: 1666.
https://doi.org/10.3390/jcm9061666
APA Style
Yoon, W. J., Oh, Y., Yoo, C., Jang, S., Cho, S.-S., Suh, J.-H., Choi, S.-S., & Park, D. H.
(2020). EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. Journal of Clinical Medicine, 9(6), 1666.
https://doi.org/10.3390/jcm9061666